Answers are grounded in this paper and cite their sources.
Emerging technologies like VR and AI show promise for preclinical diagnostics, but thorough validation and regulation for clinical safety and efficacy are necessary. Continued technological advancements are expected to enhance early detection and management of AD.
No takes yet. Share an insight, caveat, or question.
Parada et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: